Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
-0.060 (-2.49%)
Jun 25, 2024, 3:27 PM EDT - Market open

Akoya Biosciences Revenue

Akoya Biosciences had revenue of $93.57M in the twelve months ending March 31, 2024, with 17.89% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $18.35M, a -14.29% decrease year-over-year. In the year 2023, Akoya Biosciences had annual revenue of $96.63M with 29.09% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
116.06M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202396.63M21.77M29.09%
Dec 31, 202274.86M19.94M36.31%
Dec 31, 202154.92M12.47M29.39%
Dec 31, 202042.44M207.00K0.49%
Dec 31, 201942.24M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.57M
FibroGen 167.49M
Assertio Holdings 142.05M
Seres Therapeutics 126.85M
G1 Therapeutics 84.04M
Revenue Rankings